Aastrom Biosciences (ASTM)

Aastrom Biosciences' (ASTM) CEO Nick Colangelo on Q3 2014 Results - Earnings Call Transcript
Nov. 13, 2014 | Price: Free! | Source: Seeking Alpha

Aastrom Biosciences (ASTM) Q2 2014 Results - Earnings Call Webcast
Aug. 14, 2014 | Price: Free! | Source: Seeking Alpha

Aastrom Biosciences' (ASTM) CEO Dominick Colangelo on Q2 2014 Results - Earnings Call Transcript
Aug. 14, 2014 | Price: Free! | Source: Seeking Alpha

Aastrom Biosciences' (ASTM) CEO Dominick Colangelo on Q1 2014 Results - Earnings Call Transcript
May 15, 2014 | Price: Free! | Source: Seeking Alpha

Aastrom Biosciences' CEO Discusses Q4 2013 Results - Earnings Call Transcript
March 13, 2014 | Price: Free! | Source: Seeking Alpha

Aastrom Biosciences Q3 2013 Earnings Conference Call Transcript
Nov. 12, 2013 | Price: $106.00 | Source: Thomson

Aastrom Biosciences' CEO Discusses Q3 2013 Results - Earnings Call Transcript
Nov. 12, 2013 | Price: Free! | Source: Seeking Alpha

Aastrom Biosciences Q2 2013 Earnings Conference Call Transcript
Aug. 15, 2013 | Price: $106.00 | Source: Thomson

Aastrom Biosciences Management Discusses Q2 2013 Results - Earnings Call Transcript
Aug. 15, 2013 | Price: Free! | Source: Seeking Alpha

Aastrom Biosciences Management Discusses Q1 2013 Results - Earnings Call Transcript
May 9, 2013 | Price: Free! | Source: Seeking Alpha

Aastrom Biosciences Q1 2013 Earnings Conference Call Transcript
May 8, 2013 | Price: $106.00 | Source: Thomson

Aastrom Biosciences Management Discusses Q4 2012 Results - Earnings Call Transcript
March 18, 2013 | Price: Free! | Source: Seeking Alpha

Aastrom Biosciences Q4 2012 Earnings Conference Call Transcript
March 18, 2013 | Price: $106.00 | Source: Thomson

Aastrom Biosciences' CEO Discusses Q3 2012 Results - Earnings Call Transcript
Nov. 9, 2012 | Price: Free! | Source: Seeking Alpha

Aastrom Biosciences Q3 2012 Earnings Conference Call Transcript
Nov. 8, 2012 | Price: $54.00 | Source: Thomson

Aastrom Biosciences' CEO Discusses Q2 2012 Results - Earnings Call Transcript
Aug. 8, 2012 | Price: Free! | Source: Seeking Alpha

Aastrom Biosciences Q2 2012 Earnings Conference Call Transcript
Aug. 7, 2012 | Price: $54.00 | Source: Thomson

Aastrom Biosciences, Inc. Q2 2008 Earnings Call Transcript
Feb. 8, 2008 | Price: Free! | Source: Seeking Alpha

Recent filings

Aastrom Biosciences insider just cashed-in 17,500 options - May 14, 2019

Aastrom Biosciences Just Filed Its Quarterly Report: Net Loss Per Common ... - May 7, 2019

Aastrom: 02. Results Of Operations And Financial Condition - May 7, 2019

Aastrom: Vericel Enters Into Exclusive License Agreement With Mediwound For North American Rights To Nexobrid, A Biological Orphan Product For Debridement Of Severe Thermal Burns - May 7, 2019

Entry into a Material Definitive - May 7, 2019

Aastrom Biosciences insider just cashed-in 7,500 options - May 3, 2019

Aastrom Biosciences insider was just granted 14,875 options and restricted shares - May 3, 2019

Aastrom Biosciences insider was just granted 14,875 options and restricted shares - May 3, 2019

Aastrom Biosciences insider was just granted 14,875 options and restricted shares - May 3, 2019

Aastrom Biosciences insider was just granted 14,875 options and restricted shares - May 3, 2019

Aastrom Biosciences insider was just granted 14,875 options and restricted shares - May 3, 2019

Securities to be offered to employees in employee benefit plans - May 1, 2019

Securities to be offered to employees in employee benefit plans, post-effective amendments - May 1, 2019

Securities to be offered to employees in employee benefit plans, post-effective amendments - May 1, 2019

Securities to be offered to employees in employee benefit plans, post-effective amendments - May 1, 2019

Departure of Directors or Certain - May 1, 2019

Securities to be offered to employees in employee benefit plans, post-effective amendments - May 1, 2019

Securities to be offered to employees in employee benefit plans, post-effective amendments - May 1, 2019

Securities to be offered to employees in employee benefit plans, post-effective amendments - May 1, 2019

Securities to be offered to employees in employee benefit plans, post-effective amendments - May 1, 2019

Aastrom Biosciences insider just cashed-in 15,625 options - April 10, 2019

Aastrom Biosciences releases salary data. CEO sees compensation rise 77% - March 20, 2019

Aastrom Biosciences insider just disposed of 10,000 shares - March 12, 2019

Aastrom Biosciences insider just cashed-in 7,500 options - March 4, 2019

Aastrom: 02. Results Of Operations And Financial Condition - Feb. 26, 2019

Aastrom Biosciences Just Filed Its Annual Report: Net Loss Per Share A... - Feb. 26, 2019

Aastrom Biosciences insider just picked up 36,192 shares - Feb. 19, 2019

Strategos Fund, L.P. just provided an update on share ownership of Aastrom Biosciences - Feb. 14, 2019

Mitchell Blutt just provided an update on share ownership of Aastrom Biosciences - Feb. 14, 2019

Statement of acquisition of beneficial ownership by individuals - Feb. 14, 2019

The Vanguard Group just provided an update on share ownership of Aastrom Biosciences - Feb. 12, 2019

James E. Flynn just provided an update on share ownership of Aastrom Biosciences - Feb. 12, 2019

Aastrom Biosciences's Chief Operating Officer just picked up 1,487 shares - Feb. 8, 2019

Aastrom Biosciences insider was just granted 154,000 options and restricted shares - Feb. 8, 2019

Aastrom Biosciences insider was just granted 337,750 options and restricted shares - Feb. 8, 2019

Aastrom Biosciences insider was just granted 134,500 options and restricted shares - Feb. 8, 2019

Aastrom Biosciences insider just picked up 17,500 shares - Jan. 24, 2019

Aastrom Biosciences insider just disposed of 8,711 shares - Jan. 16, 2019

Termination of a Material Definitive - Dec. 20, 2018

Aastrom Biosciences insider just cashed-in 15,625 options - Dec. 12, 2018

Aastrom Biosciences insider just cashed-in 8,500 options - Dec. 4, 2018

Aastrom: 02. Results Of Operations And Financial Condition - Nov. 6, 2018

James E. Flynn just provided an update on share ownership of Aastrom Biosciences - Oct. 22, 2018

Aastrom Biosciences insider just cashed-in 15,000 options - Oct. 17, 2018

Aastrom Biosciences insider just cashed-in 15,000 options - Sept. 12, 2018

Aastrom Biosciences insider just cashed-in 9,000 options - Sept. 6, 2018

Aastrom Biosciences Just Received a Notice of Effectiveness - Aug. 28, 2018

Registration statement under Securities Act of 1933 - Aug. 16, 2018

Aastrom Biosciences Just Filed Its Quarterly Report: Net Loss Per Common ... - Aug. 6, 2018

CFO and VP of Aastrom Biosciences just picked up 112,481 shares - Aug. 3, 2018

Aastrom Biosciences insider just cashed-in 30,000 options - June 20, 2018

Confidential treatment order - June 6, 2018

Aastrom Biosciences just filed a prospectus, suggesting it plans to soon issue some securities - June 1, 2018

Aastrom: Vericel Corporation Announces Proposed Public Offering Of Common Stock - June 1, 2018

Registration adding securities to prior Form S-3 registration [Rule 462(b)] - May 31, 2018

Terminationof a Material Definitive - May 30, 2018

Aastrom Biosciences just filed a prospectus, suggesting it plans to soon issue some securities - May 30, 2018

Aastrom Biosciences insider just picked up 474 shares - May 18, 2018

Aastrom Biosciences Just Filed Its Quarterly Report: Net Loss Per Common ... - May 8, 2018

Aastrom: 02. Results Of Operations And Financial Condition - May 8, 2018

Aastrom Biosciences insider was just granted 17,500 options - May 3, 2018

Aastrom Biosciences insider was just granted 17,500 options - May 3, 2018

Aastrom Biosciences insider was just granted 17,500 options - May 3, 2018

Submission of Matters to a Vote of Security - May 3, 2018

Aastrom Biosciences insider was just granted 17,500 options - May 3, 2018

Aastrom Biosciences insider was just granted 17,500 options - May 3, 2018

Aastrom Biosciences insider was just granted 17,500 options - May 3, 2018

Aastrom Biosciences releases salary data. CEO sees compensation rise 46% - March 22, 2018

Aastrom Biosciences insider just picked up 890 shares - March 20, 2018

KENNETH B. DART just provided an update on share ownership of Aastrom Biosciences - March 14, 2018

Aastrom: 02. Results Of Operations And Financial Condition - March 5, 2018

Aastrom Biosciences insider just picked up 34,103 shares - Feb. 22, 2018

Consonance Capital Opportunity Fund Management LP just provided an update on share ownership of Aastrom Biosciences - Feb. 14, 2018

Timothy P. Lynch just issued a filing suggesting it has sold all of its Aastrom Biosciences - Feb. 13, 2018

CFO and VP of Aastrom Biosciences just picked up 4,450 shares - Feb. 13, 2018

Aastrom Biosciences's President and CEO just picked up 8,418 shares - Feb. 13, 2018

Aastrom Biosciences's Chief Operating Officer just picked up 5,984 shares - Feb. 13, 2018

Aastrom Biosciences insider was just granted 100,000 options - Feb. 9, 2018

Aastrom Biosciences insider was just granted 100,000 options - Feb. 9, 2018

Aastrom Biosciences insider was just granted 300,000 options - Feb. 9, 2018

Strategos Fund, L.P. just provided an update on share ownership of Aastrom Biosciences - Feb. 9, 2018

Statement of acquisition of beneficial ownership by individuals - Jan. 18, 2018

Confidential treatment order - Jan. 11, 2018

Aastrom: Company Presentation January 2018 - Jan. 8, 2018

Entry into a Material Definitive - Dec. 28, 2017

Aastrom: Vericel Enters Into Expanded $25 Million Debt Facilities With Silicon Valley - Dec. 8, 2017

Aastrom Biosciences Just Filed Its Quarterly Report: Net Loss Per Common ... - Nov. 7, 2017

Aastrom: 02. Results Of Operations And Financial Condition - Nov. 7, 2017

Entry into a Material Definitive - Sept. 19, 2017

Strategos Fund, L.P. just provided an update on share ownership of Aastrom Biosciences - Aug. 28, 2017

Confidential treatment order - Aug. 14, 2017

Confidential treatment order - Aug. 10, 2017

Entry into a Material Definitive - Aug. 10, 2017

Securities to be offered to employees in employee benefit plans, post-effective amendments - Aug. 9, 2017

Securities to be offered to employees in employee benefit plans, post-effective amendments - Aug. 9, 2017

Securities to be offered to employees in employee benefit plans, post-effective amendments - Aug. 9, 2017

Aastrom Biosciences Just Filed Its Quarterly Report: Net Loss Per Common ... - Aug. 9, 2017

Securities to be offered to employees in employee benefit plans, post-effective amendments - Aug. 9, 2017

Securities to be offered to employees in employee benefit plans, post-effective amendments - Aug. 9, 2017

Current report, item 2.02 - Aug. 9, 2017

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. Consonance Capman GP LLC 2,086,028 N/A Dec. 31, 2015
2. UBS AG 1,373 N/A Sept. 30, 2014

Aastrom Biosciences (ASTM)

140

cctranscripts

May 14, 2019

Aastrom Biosciences insider just cashed-in 17,500 options http://www.conferencecalltranscripts.org/pink/summary?id=6204264

cctranscripts

May 7, 2019

Aastrom Biosciences Just Filed Its Quarterly Report: Net Loss Per Common ... http://www.conferencecalltranscripts.org/pink/summary?id=6163970

cctranscripts

May 7, 2019

Aastrom: 02. Results Of Operations And Financial Condition http://www.conferencecalltranscripts.org/pink/summary?id=6160905

cctranscripts

May 7, 2019

Aastrom: Vericel Enters Into Exclusive License Agreement With Mediwound For North American Rights To Nexobrid, A Biological Orphan Product For Debridement Of Severe Thermal Burns http://www.conferencecalltranscripts.org/pink/summary?id=6159811

cctranscripts

May 7, 2019

Entry into a Material Definitive http://www.conferencecalltranscripts.org/pink/summary?id=6159804

cctranscripts

May 3, 2019

Aastrom Biosciences insider was just granted 14,875 options and restricted shares http://www.conferencecalltranscripts.org/pink/summary?id=6150910

cctranscripts

May 3, 2019

Aastrom Biosciences insider was just granted 14,875 options and restricted shares http://www.conferencecalltranscripts.org/pink/summary?id=6150891

cctranscripts

May 3, 2019

Aastrom Biosciences insider was just granted 14,875 options and restricted shares http://www.conferencecalltranscripts.org/pink/summary?id=6150769

cctranscripts

May 3, 2019

Aastrom Biosciences insider was just granted 14,875 options and restricted shares http://www.conferencecalltranscripts.org/pink/summary?id=6150875

cctranscripts

May 3, 2019

Aastrom Biosciences insider was just granted 14,875 options and restricted shares http://www.conferencecalltranscripts.org/pink/summary?id=6150756

cctranscripts

May 3, 2019

Aastrom Biosciences insider just cashed-in 7,500 options http://www.conferencecalltranscripts.org/pink/summary?id=6150855

cctranscripts

May 1, 2019

Securities to be offered to employees in employee benefit plans, post-effective amendments http://www.conferencecalltranscripts.org/pink/summary?id=6137545

cctranscripts

May 1, 2019

Securities to be offered to employees in employee benefit plans, post-effective amendments http://www.conferencecalltranscripts.org/pink/summary?id=6137542

cctranscripts

May 1, 2019

Securities to be offered to employees in employee benefit plans, post-effective amendments http://www.conferencecalltranscripts.org/pink/summary?id=6137525

cctranscripts

May 1, 2019

Departure of Directors or Certain http://www.conferencecalltranscripts.org/pink/summary?id=6136429

cctranscripts

May 1, 2019

Securities to be offered to employees in employee benefit plans http://www.conferencecalltranscripts.org/pink/summary?id=6137517

cctranscripts

May 1, 2019

Securities to be offered to employees in employee benefit plans, post-effective amendments http://www.conferencecalltranscripts.org/pink/summary?id=6137528

cctranscripts

May 1, 2019

Securities to be offered to employees in employee benefit plans, post-effective amendments http://www.conferencecalltranscripts.org/pink/summary?id=6137529

cctranscripts

May 1, 2019

Securities to be offered to employees in employee benefit plans, post-effective amendments http://www.conferencecalltranscripts.org/pink/summary?id=6137533

cctranscripts

May 1, 2019

Securities to be offered to employees in employee benefit plans, post-effective amendments http://www.conferencecalltranscripts.org/pink/summary?id=6137556
 


Feedback